NASDAQ

Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Friday, July 3, 2020 - 8:25pm

The equity awards were granted pursuant to the NASDAQ Rule 5635(c)(4) inducement grant exception as a component of each individuals employment compensation and were granted as an inducement material to his or her acceptance of employment with Baudax Bio.

Key Points: 
  • The equity awards were granted pursuant to the NASDAQ Rule 5635(c)(4) inducement grant exception as a component of each individuals employment compensation and were granted as an inducement material to his or her acceptance of employment with Baudax Bio.
  • The options have an exercise price equal to $4.15 per share, the closing price of Baudax Bios common stock as reported by NASDAQ on June 30, 2020.
  • The equity awards are subject to each individuals continued service with Baudax Bio through the applicable vesting dates.
  • Baudax Bio is a specialty pharmaceutical company focused on therapeutics for acute care settings.

ReTo Eco-Solutions Receives Notice of Deficiency from Nasdaq Relating to the Delayed Filing of its Annual Report on Form 20-F

Thursday, July 2, 2020 - 9:30pm

ReTo is required by Nasdaq to submit its plan to regain compliance no later than August 31, 2020.

Key Points: 
  • ReTo is required by Nasdaq to submit its plan to regain compliance no later than August 31, 2020.
  • If the plan is accepted by Nasdaq, ReTo can be granted up to 180 calendar days from the Form 20-F's due date, or until December 28, 2020, to regain compliance.
  • ReTo continues to work diligently to complete the Form 20-F and file it with the SEC as soon as reasonably practicable.
  • The Company expects to submit a plan to regain compliance or file its Form 20-F within the timeline prescribed by Nasdaq.

Cinedigm to Report Fourth Quarter and FY 2020 Financial Results on Monday, July 6, 2020

Thursday, July 2, 2020 - 9:48pm

LOS ANGELES, July 02, 2020 (GLOBE NEWSWIRE) -- Cinedigm (NASDAQ: CIDM) announced today that it will release its fourth quarter and fiscal year ended 2020 financial results for the period endedMarch 31, 2020, onMonday, July 6, 2020 before the market opens.

Key Points: 
  • LOS ANGELES, July 02, 2020 (GLOBE NEWSWIRE) -- Cinedigm (NASDAQ: CIDM) announced today that it will release its fourth quarter and fiscal year ended 2020 financial results for the period endedMarch 31, 2020, onMonday, July 6, 2020 before the market opens.
  • A conference call is scheduled the same day at10:00 a.m. EDT.
  • To participate in the conference call, please dial(877) 754-5303 or for international callers(678) 894-3030 at least five minutes prior to the start of the call.
  • An audio webcast is available directly at the following link https://edge.media-server.com/mmc/p/zefcynr9 and will also be accessible at http://investor.cinedigm.com/events.cfm .

miRagen Regains Compliance With Nasdaq Listing Requirements

Thursday, July 2, 2020 - 9:15pm

BOULDER, Colo., July 02, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that on July1,2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (Nasdaq) stating that the Company regained compliance with the applicable Nasdaq minimum bid price continued listing requirement and the matter is now closed.

Key Points: 
  • BOULDER, Colo., July 02, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that on July1,2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (Nasdaq) stating that the Company regained compliance with the applicable Nasdaq minimum bid price continued listing requirement and the matter is now closed.
  • miRagen has three clinical stage product candidates, cobomarsen, remlarsen, and MRG-110.
  • In addition to these programs, miRagen is developing a pipeline of preclinical product candidates.
  • miRagen has based these forward-looking statements largely on its current expectations and projections about future events and trends.

Pyxis Tankers Announces Receipt of NASDAQ Notice

Thursday, July 2, 2020 - 10:00pm

The notice explained that due to the extraordinary market conditions caused by COVID-19, Nasdaq is providing temporary relief and tolling the compliance period until June 30, 2020.

Key Points: 
  • The notice explained that due to the extraordinary market conditions caused by COVID-19, Nasdaq is providing temporary relief and tolling the compliance period until June 30, 2020.
  • The Company is currently reviewing options to meet the requirements for continued listing on Nasdaq.
  • We own a modern fleet of five tankers engaged in seaborne transportation of refined petroleum products and other bulk liquids.
  • The information discussed contained in, or that can be accessed through, Pyxis Tankers Inc.s website, is not incorporated into, and does not constitute part of this report.

Abraxas Petroleum Receives NASDAQ Notice Regarding Non-Compliance with Continued Listing Standards

Thursday, July 2, 2020 - 9:15pm

Abraxas Petroleum Corporation (Abraxas or the Company) (NASDAQ: AXAS) today announced that on Wednesday, July 1, it received notice from The NASDAQ Stock Market LLC ("NASDAQ") that the Company is not presently in compliance with the NASDAQ continued listing rules since the Company has not yet filed its Form 10-Q for the period ended March 31, 2020.

Key Points: 
  • Abraxas Petroleum Corporation (Abraxas or the Company) (NASDAQ: AXAS) today announced that on Wednesday, July 1, it received notice from The NASDAQ Stock Market LLC ("NASDAQ") that the Company is not presently in compliance with the NASDAQ continued listing rules since the Company has not yet filed its Form 10-Q for the period ended March 31, 2020.
  • In accordance with applicable NASDAQ procedures, the Company plans to timely notify NASDAQ that it intends to pursue actions to file its Form 10-Q as soon as practicable.
  • NASDAQ provides for a period of 60 days following receipt of the notice for the Company to submit a plan to regain compliance for continued listing on the exchange.
  • The notice has no immediate impact on the listing of the Companys common stock, which will continue to trade on the NASDAQ subject to the Companys compliance with the other continued listing requirements.

Mattel Announces Second Quarter 2020 Financial Results Conference Call

Thursday, July 2, 2020 - 9:05pm

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2020 financial results on Thursday, July 23, 2020, at approximately 4:05 p.m. Eastern time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2020 financial results on Thursday, July 23, 2020, at approximately 4:05 p.m. Eastern time.
  • Following this, Mattel will host a conference call and webcast at 5:00 p.m. Eastern time.
  • The conference call will be webcast on Mattel's Investor Relations website, https://investors.mattel.com/ .
  • Since its founding in 1945, Mattel is proud to be a trusted partner in empowering children to explore the wonder of childhood and reach their full potential.

First Merchants Corporation to Report Second Quarter 2020 Financial Results, Host Conference Call and Webcast

Thursday, July 2, 2020 - 7:10pm

MUNCIE, Ind., July 02, 2020 (GLOBE NEWSWIRE) -- First Merchants Corporation (Nasdaq:FRME) will report second quarter 2020 financial results on July 23, 2020.

Key Points: 
  • MUNCIE, Ind., July 02, 2020 (GLOBE NEWSWIRE) -- First Merchants Corporation (Nasdaq:FRME) will report second quarter 2020 financial results on July 23, 2020.
  • The Corporation will host a second quarter 2020 earnings conference call and webcast at 2:30 p.m. (ET) on Thursday, July 23, 2020.
  • To participate, dial (Toll Free) 877-507-0578 and reference First Merchants Corporations second quarter earnings release.
  • FIRST MERCHANTS and the Shield Logo are federally registered trademarks of First Merchants Corporation.

Seacoast Banking Corporation of Florida to Announce Second Quarter Earnings Results July 23, 2020

Thursday, July 2, 2020 - 6:54pm

STUART, Fla., July 02, 2020 (GLOBE NEWSWIRE) -- Seacoast Banking Corporation of Florida (NASDAQ: SBCF), a bank holding company whose operating entity is Seacoast Bank, today announced it will release second quarter results July 23rd, after the market closes.

Key Points: 
  • STUART, Fla., July 02, 2020 (GLOBE NEWSWIRE) -- Seacoast Banking Corporation of Florida (NASDAQ: SBCF), a bank holding company whose operating entity is Seacoast Bank, today announced it will release second quarter results July 23rd, after the market closes.
  • Upon release, investors may access a copy of Seacoasts earnings results at the companys website www.SeacoastBanking.com on the home page under Press Releases.
  • Seacoast will host a conference call July 24th at 10:00 a.m. Eastern Time, to discuss the earnings results and business trends.
  • About Seacoast Banking Corporation of Florida (NASDAQ: SBCF)
    Seacoast Banking Corporation of Florida is one of the largest community banks headquartered in Florida with approximately $7.4 billion in assets and $5.9 billion in deposits as of March 31, 2020.

Altabancorp™ Schedules Second Quarter 2020 Earnings Release Date and Conference Call

Thursday, July 2, 2020 - 6:15pm

AMERICAN FORK, Utah, July 02, 2020 (GLOBE NEWSWIRE) -- AltabancorpTM (Nasdaq: ALTA) announced that it will report its second quarter 2020 financial results on Wednesday, July 29, 2020 after the market closes.

Key Points: 
  • AMERICAN FORK, Utah, July 02, 2020 (GLOBE NEWSWIRE) -- AltabancorpTM (Nasdaq: ALTA) announced that it will report its second quarter 2020 financial results on Wednesday, July 29, 2020 after the market closes.
  • Management will host a conference call on Thursday, July 30, 2020 at 10:00 a.m. MDT (12:00 p.m. EDT) to discuss the Companys financial performance.
  • Please dial in 10-15 minutes early so the name and company information may be collected prior to the start of the conference.
  • Forward-looking statements may be made and other material information may be discussed on this conference call.